|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/16 | (2006.01) |
| A61K 9/1623 | (2013.01) | ||
| A61K 31/506 | (2006.01) | ||
| A61K 9/1635 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61K 9/1641 | (2013.01) | ||
| A61P 35/02 | (2006.01) | ||
| A61K 31/506 | (2013.01) | ||
| A61P 43/00 | (2006.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 35/02 | (2018.01) | ||
| A61P 43/00 | (2018.01) |
| (11) | Number of the document | 3009128 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15184282.0 |
| Date of filing the European patent application | 2007-09-25 | |
| (97) | Date of publication of the European application | 2016-04-20 |
| (45) | Date of publication and mention of the grant of the patent | 2023-07-05 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 06121371 | 2006-09-27 | EP |
| (72) |
BRUNEAU, Nathalie , FR
|
| (73) |
Novartis AG ,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | PHARMACEUTICAL COMPOSITIONS COMPRISING NILOTINIB |
| PHARMACEUTICAL COMPOSITIONS COMPRISING NILOTINIB |